Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NDX 3315

Drug Profile

NDX 3315

Alternative Names: NDX-3315; NDX33-0

Latest Information Update: 07 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NexEos Bio
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Eosinophilic oesophagitis
  • New Molecular Entity No

Highest Development Phases

  • Phase I Eosinophilic oesophagitis

Most Recent Events

  • 02 Jan 2024 Phase-I clinical trials in Eosinophilic oesophagitis (Diagnosis, In children) in USA (PO), prior to January 2024 (NexEos Bio pipeline, January 2024)
  • 13 Mar 2023 US Food and Drug Administration (FDA) approves IND application for NDX 3315 in management of eosinophilic esophagitis (PO) (NexEos Bio pipeline, March 2023)
  • 20 Jan 2023 Phase-I clinical trials in Eosinophilic oesophagitis (Diagnosis, In the elderly, In adults, In children, In volunteers) in USA (PO) (NCT05757856)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top